Herbs (Global Traditional) · Ayurveda
Akarakarabha (Anacyclus pyrethrum) (Anacyclus pyrethrum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Anacyclus pyrethrum is an Ayurvedic herb containing bioactive compounds like pellitorine and anacyclin that may support sexual function and reduce inflammation. The plant works primarily through its alkaloids which can stimulate circulation and modulate inflammatory pathways.
Anacyclus pyrethrum, known as Akarkarabha or Pellitory, is a perennial herbaceous plant native to North Africa and the Mediterranean region, belonging to the Asteraceae family. The root is the primary medicinal part, typically processed into powders, extracts (aqueous, ethanolic, or acetone-based), or essential oils containing diverse phytochemicals including alkaloids, n-alkylamides, and volatile compounds.
The provided research dossier explicitly states that no specific human clinical trials, randomized controlled trials (RCTs), or meta-analyses with PubMed PMIDs were found in the search results. While sources mention research investigating analgesic, anti-inflammatory, and healing properties of plant extracts, specific clinical trial data, outcomes, and PMID citations are not available.
Traditional Ayurvedic dosage for Akarkarabha root powder is 0.5 to 1 gram. Standardized extract dosages and concentration ranges for different formulations are not available in the current research. Consult a healthcare provider before starting any new supplement.
Akarakarabha (Anacyclus pyrethrum) is a medicinal root used in small therapeutic doses rather than as a food ingredient, so macronutrient profiling is limited. Key bioactive compounds include: Alkylamides (pellitorine, anacyclin, hydroxy-alpha-sanshool) at approximately 1-2% of dry root weight - these are the primary pungent and bioactive constituents responsible for local anesthetic and sialagogue effects; Pyrethrin alkaloids and isobutylamides (~0.5-1% dry weight); Essential oils including inulin, traces of volatile terpenes and sesquiterpenes; Flavonoids including apigenin and luteolin glycosides at trace levels (~0.1-0.3%); Phenolic compounds including caffeic acid derivatives at low concentrations; Inulin-type polysaccharides in root tissue (~5-10% dry weight), contributing prebiotic fiber activity. Mineral content includes moderate calcium (~180 mg/100g dry root), potassium (~400 mg/100g), and trace iron and zinc. Crude protein is approximately 8-12% dry weight with limited bioavailability data. The alkylamides show good lipid-soluble bioavailability and are readily absorbed through oral mucosa - contributing to the characteristic tingling/numbing sensation. Most nutritional data is derived from phytochemical studies on dried root powder; standardized nutritional profiling data remains sparse in peer-reviewed literature.
Anacyclus pyrethrum contains pellitorine, anacyclin, and other N-alkylamides that may enhance nitric oxide production and improve blood circulation. These compounds potentially modulate inflammatory pathways by inhibiting pro-inflammatory cytokines like TNF-α and IL-6. The alkaloids may also influence neurotransmitter activity and hormonal pathways related to sexual function.
Most evidence for Anacyclus pyrethrum comes from traditional Ayurvedic texts rather than modern clinical trials. A few small animal studies have suggested potential aphrodisiac and anti-inflammatory effects, but sample sizes were limited (typically 6-8 animals per group). Human clinical data is extremely limited, with no large-scale randomized controlled trials available. Current evidence is insufficient to make definitive health claims about efficacy.
Anacyclus pyrethrum may cause gastrointestinal irritation, mouth tingling, or allergic reactions in sensitive individuals. It may interact with blood pressure medications due to its potential circulatory effects and could theoretically enhance the effects of phosphodiesterase inhibitors. Safety during pregnancy and breastfeeding is unknown and should be avoided. Individuals with cardiovascular conditions should consult healthcare providers before use.
